A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD

Chest

Volumn 111, Issue 6, 1997, Pages 1622-1630

  Sajkov, Dimitar ^a   Wang, Tingting ^a   Frith, Peter A ^a   Bune, Alexandra J ^a   Alpers, John A ^b   McEvoy, R Douglas ^a  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Amlodipine; COPD; Felodipine; Pulmonary hypertension; Vasodilation

Indexed keywords

AMLODIPINE; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; FELODIPINE;

ADULT; AGED; ANKLE EDEMA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SUSTAINED RELEASE PREPARATION;

EID: 0030912187     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.6.1622     Document Type: Article

References (34)

1. Burrows B, Kettel LJ, Niden AH, et al. Patterns of cardiovascular dysfunction in chronic obstructive lung disease. N Engl J Med 1972; 272:912-18
2. Weitzenblum E, Hirth C, Duclone A, et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36:752-58
3. Agustoni P, Doria E, Galli C, et al. Nifedipine reduces pulmonary pressure and vasodilator tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 139:120-25
4. Kennedy T, Michael J, Huang C, et al. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1984; 129:544-51
5. Morley T, Zappasodi S, Belli A, et al. Pulmonary vasodilator therapy for chronic obstructive pulmonary disease and cor pulmonale: treatment with nifedipine, nitroglycerin, and oxygen. Chest 1987; 92:71-76
6. Weitzenblum E, Kessler R, Oswald M, et al. Medical treatment of pulmonary hypertension in chronic lung disease. Eur Respir J 1994; 7:148-52
7. White KF, Flenley DC. Can pulmonary vasodilators improve survival in cor pulmonale due to hypoxic chronic bronchitis and emphysema? Thorax 1988; 43:1-8
8. Ashutosh K, Dunsky M. Noninvasive tests for responsiveness of pulmonary hypertension to oxygen: prediction of survival in patients with chronic obstructive lung disease and cor pulmonale. Chest 1987; 92:393-99
9. Timms RM, Khaja FU, Williams GW, et al. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 1985; 102:29-36
10. Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1:681-86
11. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 1980; 93:391-98
12. Macnee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease (part two). Am J Respir Crit Care Med 1994; 150:1158-68
13. Salvaterra CG, Rubin LJ. Investigation and management of pulmonary hypertension in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148:1414-17
14. Karla L, Bone MF. Effect of nifedipine on physiological shunting and oxygenation in chronic obstructive pulmonary disease. Am J Med 1993; 94:419-23
15. Melot C, Hallemans R, Naeije R, et al. Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984; 130:612-16
16. Mookherjee S, Ashutosh K, Dunsky M, et al. Nifedipine in chronic cor pulmonale: acute and relatively long-term effects. Clin Pharmacol Ther 1988; 44:289-96
17. Rich S, Brundage BH. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation 1987; 76:135-41
18. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327:76-81
19. Saadjian A, Philip-Joet F, Arnaud A. Hemodynamic and oxygen delivery: responses to nifedipine in pulmonary hypertension secondary to chronic obstructive lung diseases. Cardiology 1987; 74:196-204
20. Saadjian AY, Philip-Joet FF, Vestri R, et al. Long-term treatment of chronic obstructive lung disease by nifedipine: an 18 month hemodynamic study. Eur Respir J 1988; 1:716-20
21. Bratel T, Hedenstierna G, Lindquist H, et al. Cardiac function and central hemodynamics in severe chronic obstructive lung disease: acute and long-term effects of felodipine. Eur Respir J 1988; 1:262-68
22. Bratel T, Hedenstiern G, Nyquist O, et al. The use of vasodilator, felodipine, as an adjuvant to long-term oxygen treatment in COLD patients. Eur J Respir Dis 1990; 3:46-54
23. Rubin LJ, Moser K. Long-term effects of nitrendipine on hemodynamics and oxygen transport in patients with cor pulmonale. Chest 1986; 89:141-45
24. Sajkov D, McEvoy RD, Cowie RJ, et al. Felodipine improves pulmonary hemodynamics in chronic obstructive pulmonary disease. Chest 1993; 103:1354-61
25. Hossie J, Brenmer AD, Fell PJ, et al. Comparison of early side effects with amlodipine and nifedipine retard in hypertension. Cardiology 1992; 80(suppl 1):54-59
26. Kleinbloesein CH, von Brummelen P, Danhof M, et al. Rate of inerease in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clin Pharmacol Ther 1987; 41:26-30
27. Morera J, Hoadley SD, Roland JM, et al. Estimation of the ratio of pulmonary to systemic pressures by pulsed-wave Doppler echocardiography for assessment of pulmonary arterial pressures. Am J Cardiol 1989; 63:862-66
28. Spodick DH, Koito H. Nongeometric Doppler stroke volume determination. Am J Cardiol 1989; 63:883-84
29. Sajkov D, Cowie RJ, Bradley JA, et al. Validation of new pulsed Doppler echocardiographic techniques for assessment of pulmonary hemodynamics. Chest 1993; 103:1348-53
30. Bratel T, Herdenstierna G, Nyquist O, et al. Long-term treatment with a new calcium antagonist, felodipine, in chronic obstructive lung disease. Eur Respir J 1986; 68: 351-61
31. Koenig W. Efficacy and tolerability of felodipine and amlodipine in the treatment of mild to moderate hypertension: a randomised double-blind multicentre trial. Drug Invest 1993; 5:200-05
32. Hoegholm A, Winberg N, Rasmussen E, et al. Comparative effects of amlodipine and felodipine ER on office and ambulatory blood pressure in patients with mild to moderate hypertension: Danish Multicentre Group. J Hypertens 1995; 9(suppl 1):25-28
33. Bainbridge AD, Herlihy O, Meredith PA, et al. A comparative assessment of amlodipine and felodipine ER: pharmacokinetic and pharmacodynamic indices. Eur J Clin Pharmacol 1993; 45:425-30
34. Bach LA, Sharpe K. Sample size for clinical and biological research. Aust NZ J Med 1989; 19:64-68